Quantinno Capital Management LP grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 113,867 shares of the healthcare conglomerate’s stock after buying an additional 13,505 shares during the quarter. UnitedHealth Group accounts for approximately 0.6% of Quantinno Capital Management LP’s portfolio, making the stock its 19th largest holding. Quantinno Capital Management LP’s holdings in UnitedHealth Group were worth $57,601,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in UNH. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Norges Bank purchased a new position in UnitedHealth Group in the fourth quarter worth about $6,375,744,000. Northern Trust Corp raised its position in UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. lifted its position in UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Down 17.8%
Shares of UnitedHealth Group stock opened at $311.23 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $309.10 and a 12 month high of $630.73. The business has a fifty day simple moving average of $482.53 and a 200 day simple moving average of $519.28. The stock has a market cap of $282.33 billion, a PE ratio of 20.08, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.
Analyst Ratings Changes
UNH has been the subject of several recent analyst reports. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. KeyCorp dropped their price target on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday, April 21st. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $596.86.
View Our Latest Stock Report on UNH
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How to Invest in Biotech Stocks
- Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
- Stock Analyst Ratings and Canadian Analyst Ratings
- AppLovin Surges on Earnings: What’s Next for This Tech Standout?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- U.S. Regulators Target CrowdStrike: Is It a Signal or Noise?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.